Patients on GLP-1 drugs who are experiencing a plateau may also want to talk with their doctor about considering a dose adjustment, medication switch or adding an additional drug
Finally, while many people experience positive results, not every patient qualifies, and some will find alternative approaches to be a better fit
Antibodies and small molecules that interact with incretin targets are also being developed, as well as agents to modulate mitochondrial function, fatty acid receptors and receptors for selected gastrointestinal and adipocyte peptides that affect appetite or pathways of nutrient metabolism
Think of it like blood pressure or diabetes medicationongoing treatment manages a chronic condition rather than curing it
4-Hydroxyalk-2-enals are substrates for glutathione transferase
These side effects last a short period of time, usually less than 1-2 weeks, after which time they resolve altogether